Adderall Sudden Death

 

Do I have an Adderall case?


Resources on the Web


Heart problems and deaths from Adderall


The problem is that while Health Canada is acting proactively on behalf of patients taking Adderall XR and Adderall, the FDA does nothing. There have been 20 international reports of sudden death in patients taking either Adderall (sold in the United States, not in Canada) or Adderall XR (sold in Canada). These Adderall-related deaths were not associated with overdose, misuse, or abuse.

If the FDA doesnt take this seriously who will?

The FDA concluded that in the pediatric population, potential risk factors include cardiac abnormalities that may be undiagnosed, positive family history for ventricular arrhythmias -- and as yet -- unidentified factors that may cause excessive levels of stimulant to accumulate in children who are taking what appears to be normal doses.

Do you need an expert Adderall lawyer to file an Adderall lawsuit on your behalf?

Health Canada, the counterpart agency similar to the U.S. Food and Drug Administration (FDA), suspends the market authorization of Adderall XR, a drug prescribed for Attention Deficit Hyperactivity Disorder (ADHD) in children and adults.

As of February 2005, Health Canada informed Canadians that it has instructed Shire Pharmaceuticals Group plc, the manufacturer of Adderall XR, to withdraw it from the Canadian pharmaceutical marketplace. Adderall XR, a Central Nervous System (CNS) stimulant, was approved in Canada on January 23, 2004.

Health Canada has suspended Adderall XRs marketing authorization due to safety information concerning the association of sudden deaths, heart-related deaths, and strokes in children and adults taking the usual recommended doses of Adderall and Adderall XR. The immediate release form of Adderall has never been marketed in Canada.

Health Canada is advising patients who are currently being treated with Adderall XR to talk to their doctor immediately about using Adderall XR and select safer treatment alternatives.

A Canadian preliminary review of safety data for the other related stimulants authorized for use in ADHD treatment has been conducted. In that review, the incidence of serious adverse reactions leading to death was higher in Adderall and Adderall XR combined than in the other drugs of this class.

Health Canada has asked manufacturers of other related stimulants approved for the treatment of ADHD to provide a thorough review of their worldwide safety data. Information updates will be provided by Health Canada as they become available.

If you or your child has taken Adderall and heart damage or stroke has been diagnosed, contact an expert Adderall lawyer today for a free NO-OBLIGATION lawsuit inquiry.

 


PERSONAL INFORMATION


First Name:
Last Name:
E-mail Address:
Address:
City:
State:
Zipcode:
Phone: () - ext.


CASE INFORMATION


Has a doctor said that you, a family member, or some other person you know had a serious side effect caused by Adderall?
Yes
No
Please describe:
Was Adderall a contributing factor in his or her death?
Yes
No
Please indicate which condition(s) the doctor diagnosed; check all that apply:
Sudden Unexplained Death (SUD)
Cardiovascular Problems
Myocardial infarction
Unstable angina
Cardiac thrombus
Resuscitated cardiac arrest
Ischemic stroke
Transient ischemic attacks (TIA)
Other adverse side effect(s):
Would the case you are describing be a personal injury case or a wrongful death case:
Is this for you or someone else, and if it is for someone else, what is his or her relationship to you?
What was the date of the initial diagnosis of the Adderall side effect:
If there was a death from Adderall, on what date did it occur:
What is the date of birth of the person who had an adverse reaction to Adderall:
Has a lawsuit been filed concerning the Adderall side effect:
Yes
No
What dosage of Adderall was prescribed? (See pictures to determine dosage)
Philadelphia Lawyers - Pennsylvania Lawsuits at Monheit Law

Law Offices of Michael Monheit 1368 Barrowdale Road  Rydal, PA  19046
Call Us Toll Free: 866-761-1385  P: 215-840-6573  E: Michael@Monheit.com